These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32223601)

  • 1. One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults.
    Martinez AI; Abner EL; Jicha GA; Rigsby DN; Eckmann LC; Huffmyer MJ; Moga DC
    J Manag Care Spec Pharm; 2020 Apr; 26(4):520-528. PubMed ID: 32223601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment.
    Taylor-Rowan M; Alharthi AA; Noel-Storr AH; Myint PK; Stewart C; McCleery J; Quinn TJ
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD015405. PubMed ID: 38063254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden.
    Moga DC; Abner EL; Rigsby DN; Eckmann L; Huffmyer M; Murphy RR; Coy BB; Jicha GA
    Alzheimers Res Ther; 2017 May; 9(1):36. PubMed ID: 28535785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study.
    Smith NI; Martinez AI; Huffmyer M; Eckmann L; George R; Abner EL; Jicha GA; Moga DC
    BMC Geriatr; 2023 Mar; 23(1):137. PubMed ID: 36894900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post Hoc Analyses of a Randomized Controlled Trial for the Effect of Pharmacist Deprescribing Intervention on the Anticholinergic Burden in Frail Community-Dwelling Older Adults.
    Nishtala PS; Pickering JW; Bergler U; Mangin D; Hilmer SN; Jamieson H
    J Am Med Dir Assoc; 2023 Aug; 24(8):1253-1260. PubMed ID: 37339754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Weffald LA; Green AR; Reeve E; Maciejewski ML; Sheehan OC; Wolff JL; Kraus C; Boyd CM
    JAMA Intern Med; 2022 May; 182(5):534-542. PubMed ID: 35343999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol.
    Moga DC; Beech BF; Abner EL; Schmitt FA; El Khouli RH; Martinez AI; Eckmann L; Huffmyer M; George R; Jicha GA
    Trials; 2019 Dec; 20(1):806. PubMed ID: 31888732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
    Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
    Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
    JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
    Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
    Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of anticholinergic burden of medications in older adults.
    West T; Pruchnicki MC; Porter K; Emptage R
    J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing anticholinergic medication exposure among older adults using consumer technology: Protocol for a randomized clinical trial.
    Abebe E; Campbell NL; Clark DO; Tu W; Hill JR; Harrington AB; O'Neal G; Trowbridge KS; Vallejo C; Yang Z; Bo N; Knight A; Alamer KA; Carter A; Valenzuela R; Adeoye P; Boustani MA; Holden RJ
    Res Social Adm Pharm; 2021 May; 17(5):986-992. PubMed ID: 33773639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
    Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial.
    Jamieson H; Nishtala PS; Bergler HU; Weaver SK; Pickering JW; Ailabouni NJ; Abey-Nesbit R; Gullery C; Deely J; Gee SB; Hilmer SN; Mangin D
    J Gerontol A Biol Sci Med Sci; 2023 Aug; 78(9):1692-1700. PubMed ID: 36692224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
    J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.